Commentary: The unacceptable aortic risk with fluoroquinolone exposure in Marfan syndrome
J Thorac Cardiovasc Surg
.
2022 Mar;163(3):e227-e228.
doi: 10.1016/j.jtcvs.2020.09.115.
Epub 2020 Oct 5.
Authors
Leora B Balsam
1
,
William D Hoffman
2
Affiliations
1
Division of Cardiac Surgery, UMass Memorial Medical Center, Worcester, Mass. Electronic address: leora.balsam@umassmemorial.org.
2
Department of Anesthesiology and Perioperative Medicine, UMass Memorial Medical Center, Worcester, Mass.
PMID:
33268123
DOI:
10.1016/j.jtcvs.2020.09.115
No abstract available
Publication types
Editorial
Comment
MeSH terms
Aorta
Aortic Dissection*
Fluoroquinolones / adverse effects
Humans
Marfan Syndrome* / complications
Marfan Syndrome* / diagnosis
Substances
Fluoroquinolones